Peripheral sensitization increases opioid receptor expression and activation by crotalphine in rats

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Zambelli, Vanessa Olzon ^a   Fernandes, Ana Carolina De Oliveira ^a   Gutierrez, Vanessa Pacciari ^a   Ferreira, Julio Cesar Batista ^b   Parada, Carlos Amilcar ^c   Mochly Rosen, Daria ^d   Cury, Yara ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CROTALPHINE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; PEPTIDE; PROSTAGLANDIN E2; PROTEIN KINASE C LAMBDA; SNAKE VENOM; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG ADMINISTRATION ROUTE; GENE ACTIVATION; GENE EXPRESSION REGULATION; HYPERALGESIA; INTRACELLULAR SIGNALING; INTRAPLANTAR DRUG ADMINISTRATION; MALE; NERVE CELL CULTURE; NONHUMAN; RAT; RECEPTOR AFFINITY; SPINAL GANGLION; UPREGULATION;

ANALGESICS, OPIOID; ANIMALS; CROTALUS; DINOPROSTONE; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; HYPERALGESIA; MALE; PEPTIDES; RATS; RATS, WISTAR; RECEPTORS, OPIOID;

EID: 84897090855     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090576     Document Type: Article

References (58)

1. Stein C (1993) Peripheral mechanisms of opioid analgesia. Anesth Analg 76: 182-191.
2. Obara I, Parkitna JR, Korostynski M, Makuch W, Kaminska D, et al. (2009) Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain. Pain 141: 283-291.
3. Puehler W, Zollner C, Brack A, Shaqura MA, Krause H, et al. (2004) Rapid upregulation of mu opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction. Neuroscience 129: 473-479. (Pubitemid 39388866)
4. Maekawa K, Minami M, Masuda T, Satoh M (1996) Expression of mu- and kappa-, but not delta-, opioid receptor mRNAs is enhanced in the spinal dorsal horn of the arthritic rats. Pain 64: 365-371. (Pubitemid 26130873)
5. Cahill CM, Morinville A, Hoffert C, O'Donnell D, Beaudet A (2003) Up-regulation and trafficking of delta opioid receptor in a model of chronic inflammation: implications for pain control. Pain 101: 199-208. (Pubitemid 36044668)
6. Hassan AH, Ableitner A, Stein C, Herz A (1993) Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 55: 185-195. (Pubitemid 23194996)
7. Zollner C, Shaqura MA, Bopaiah CP, Mousa S, Stein C, et al. (2003) Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol 64: 202-210. (Pubitemid 36909983)
8. Shaqura MA, Zollner C, Mousa SA, Stein C, Schafer M (2004) Characterization of mu opioid receptor binding and G protein coupling in rat hypothalamus, spinal cord, and primary afferent neurons during inflammatory pain. J Pharmacol Exp Ther 308: 712-718. (Pubitemid 38134235)
9. Antonijevic I, Mousa SA, Schafer M, Stein C (1995) Perineurial defect and peripheral opioid analgesia in inflammation. J Neurosci 15: 165-172.
10. Mousa SA, Zhang Q, Sitte N, Ji R, Stein C (2001) beta-Endorphin- containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol 115: 71-78. (Pubitemid 32245655)
11. Konno K, Picolo G, Gutierrez VP, Brigatte P, Zambelli VO, et al. (2008) Crotalphine, a novel potent analgesic peptide from the venom of the South American rattlesnake Crotalus durissus terrificus. Peptides.
12. Gutierrez VP, Zambelli VO, Picolo G, Chacur M, Sampaio SC, et al. The peripheral L-arginine-nitric oxide-cyclic GMP pathway and ATP-sensitive K channels are involved in the antinociceptive effect of crotalphine on neuropathic pain in rats. Behav Pharmacol 23: 14-24.
13. Gutierrez VP, Konno K, Chacur M, Sampaio SC, Picolo G, et al. (2008) Crotalphine induces potent antinociception in neuropathic pain by acting at peripheral opioid receptors. Eur J Pharmacol 594: 84-92.
14. Granados-Soto V, Rufino MO, Gomes Lopes LD, Ferreira SH (1997) Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. Eur J Pharmacol 340: 177-180. (Pubitemid 28022639)
15. Sachs D, Cunha FQ, Ferreira SH (2004) Peripheral analgesic blockade of hypernociception: activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K+ channel pathway. Proc Natl Acad Sci U S A 101: 3680-3685. (Pubitemid 38338254)
16. Pacheco DF, Reis GM, Francischi JN, Castro MS, Perez AC, et al. (2005) delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway. Life Sci 78: 54-60. (Pubitemid 41527231)
17. Amarante LH, Duarte ID (2002) The kappa-opioid agonist (+/-)-bremazocine elicits peripheral antinociception by activation of the L-arginine/nitric oxide/cyclic GMP pathway. Eur J Pharmacol 454: 19-23. (Pubitemid 35284361)
18. Cunha TM, Roman-Campos D, Lotufo CM, Duarte HL, Souza GR, et al. Morphine peripheral analgesia depends on activation of the PI3Kgamma/AKT/nNOS/NO/KATP signaling pathway. Proc Natl Acad Sci U S A 107: 4442-4447.
19. Law BK, Waltner-Law ME, Entingh AJ, Chytil A, Aakre ME, et al. (2000) Salicylate-induced growth arrest is associated with inhibition of p70s6k and down-regulation of c-myc, cyclin D1, cyclin A, and proliferating cell nuclear antigen. J Biol Chem 275: 38261-38267. (Pubitemid 32009146)
20. Belcheva MM, Clark AL, Haas PD, Serna JS, Hahn JW, et al. (2005) Mu and kappa opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes. J Biol Chem 280: 27662-27669. (Pubitemid 41076879)
21. Connor M, Christie MD (1999) Opioid receptor signalling mechanisms. Clin Exp Pharmacol Physiol 26: 493-499. (Pubitemid 29309619)
22. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.
23. Picolo G, Giorgi R, Bernardi MM, Cury Y (1998) The antinociceptive effect of Crotalus durissus terrificus snake venom is mainly due to a supraspinally integrated response. Toxicon 36: 223-227. (Pubitemid 28204416)
24. Segond von Banchet G, Scholze A, Schaible HG (2003) Prostaglandin E2 increases the expression of the neurokinin1 receptor in adult sensory neurones in culture: a novel role of prostaglandins. Br J Pharmacol 139: 672-680. (Pubitemid 36819637)
25. Picolo G, Giorgi R, Cury Y (2000) delta-opioid receptors and nitric oxide mediate the analgesic effect of Crotalus durissus terrificus snake venom. Eur J Pharmacol 391: 55-62. (Pubitemid 30138080)
26. Gendron L, Pintar JE, Chavkin C (2007) Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia. Neuroscience 150: 807-817. (Pubitemid 350235793)
27. Lomas LM, Barrett AC, Terner JM, Lysle DT, Picker MJ (2007) Sex differences in the potency of kappa opioids and mixed-action opioids administered systemically and at the site of inflammation against capsaicin-induced hyperalgesia in rats. Psychopharmacology (Berl) 191: 273-285. (Pubitemid 46354621)
28. {Ji J, Y., Murphy AZ, Traub RJ (2007) Estrogen modulation of morphine analgesia of visceral pain in female rats is supraspinally and peripherally mediated. J Pain 8: 494-502.
29. Picolo G, Cury Y (2004) Peripheral neuronal nitric oxide synthase activity mediates the antinociceptive effect of Crotalus durissus terrificus snake venom, a delta- and kappa-opioid receptor agonist. Life Sci 75: 559-573. (Pubitemid 38670263)
30. Randall LO, Selitto JJ (1957) A method for measurement of analgesia activity on inflamed tissue. Arch Inst Pharmacodyn 111: 209-219.
31. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
32. Gupta A, Decaillot FM, Gomes I, Tkalych O, Heimann AS, et al. (2006) Conformation state sensitive antibodies to G-protein coupled receptors. J Biol Chem.
33. Cunha TM, Souza GR, Domingues AC, Carreira EU, Lotufo CM, et al. Stimulation of peripheral Kappa opioid receptors inhibits inflammatory hyperalgesia via activation of the PI3Kgamma/AKT/nNOS/NO signaling pathway. Mol Pain 8: 10.
34. Bruchas MR, Chavkin C Kinase cascades and ligand-directed signaling at the kappa opioid receptor. Psychopharmacology (Berl) 210: 137-147.
35. Berra E, Diaz-Meco MT, Dominguez I, Municio MM, Sanz L, et al. (1993) Protein kinase C zeta isoform is critical for mitogenic signal transduction. Cell 74: 555-563. (Pubitemid 23244620)
36. Kwong K, Lee LY (2005) Prostaglandin E2 potentiates a TTX-resistant sodium current in rat capsaicin-sensitive vagal pulmonary sensory neurones. J Physiol 564: 437-450. (Pubitemid 40585044)
37. Southall MD, Vasko MR (2001) Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E2-induced cAMP production and sensitization of sensory neurons. J Biol Chem 276: 16083-16091.
38. Ferreira SH, Lorenzetti BB (1981) Prostaglandin hyperalgesia, IV: a metabolic process. Prostaglandins 21: 789-792.
39. Stein C, Millan MJ, Shippenberg TS, Peter K, Herz A (1989) Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J Pharmacol Exp Ther 248: 1269-1275. (Pubitemid 19100783)
40. Mousa SA, Machelska H, Schafer M, Stein C (2002) Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain. J Neuroimmunol 126: 5-15. (Pubitemid 34527131)
41. Furst S, Riba P, Friedmann T, Timar J, Al-Khrasani M, et al. (2005) Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat. J Pharmacol Exp Ther 312: 609-618. (Pubitemid 40189558)
42. Nunez S, Lee JS, Zhang Y, Bai G, Ro JY (2007) Role of peripheral mu-opioid receptors in inflammatory orofacial muscle pain. Neuroscience 146: 1346-1354. (Pubitemid 46694127)
43. Schafer M, Imai Y, Uhl GR, Stein C (1995) Inflammation enhances peripheral mu-opioid receptor-mediated analgesia, but not mu-opioid receptor transcription in dorsal root ganglia. Eur J Pharmacol 279: 165-169.
44. Zhou L, Zhang Q, Stein C, Schafer M (1998) Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. J Pharmacol Exp Ther 286: 1000-1006. (Pubitemid 29003496)
45. Lecat S, Bucher B, Mely Y, Galzi JL (2002) Mutations in the extracellular amino-terminal domain of the NK2 neurokinin receptor abolish cAMP signaling but preserve intracellular calcium responses. J Biol Chem 277: 42034-42048. (Pubitemid 35257518)
46. Decaillot FM, Befort K, Filliol D, Yue S, Walker P, et al. (2003) Opioid receptor random mutagenesis reveals a mechanism for G protein-coupled receptor activation. Nat Struct Biol 10: 629-636. (Pubitemid 36944716)
47. Selley DE, Breivogel CS, Childers SR (1993) Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins. Mol Pharmacol 44: 731-741. (Pubitemid 23317285)
48. Belcheva MM, Vogel Z, Ignatova E, Avidor-Reiss T, Zippel R, et al. (1998) Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves Gbetagamma subunits. J Neurochem 70: 635-645. (Pubitemid 28079352)
49. Bohn LM, Belcheva MM, Coscia CJ (2000) Mitogenic signaling via endogenous kappa-opioid receptors in C6 glioma cells: evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade. J Neurochem 74: 564-573. (Pubitemid 30053728)
50. Bruchas MR, Macey TA, Lowe JD, Chavkin C (2006) Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes. J Biol Chem 281: 18081-18089. (Pubitemid 44035608)
51. Sweatt JD (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 14: 311-317.
52. Thomas GM, Huganir RL (2004) MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci 5: 173-183. (Pubitemid 38252474)
53. Carlezon WA, Jr., Duman RS, Nestler EJ (2005) The many faces of CREB. Trends Neurosci 28: 436-445. (Pubitemid 40982557)
54. Bruchas MR, Xu M, Chavkin C (2008) Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2. Neuroreport 19: 1417-1422.
55. Kreibich AS, Blendy JA (2004) cAMP response element-binding protein is required for stress but not cocaine-induced reinstatement. J Neurosci 24: 6686-6692. (Pubitemid 38993888)
56. Bruchas MR, Yang T, Schreiber S, Defino M, Kwan SC, et al. (2007) Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase. J Biol Chem 282: 29803-29811. (Pubitemid 350035286)
57. Melief EJ, Miyatake M, Bruchas MR, Chavkin C (2010) Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling. Proc Natl Acad Sci U S A 107: 11608-11613.
58. Velazquez KT, Mohammad H, Sweitzer SM (2007) Protein kinase C in pain: involvement of multiple isoforms. Pharmacol Res 55: 578-589. (Pubitemid 46962305)